top of page

PK/PD Study

EnquBio provides preclinical non-GLP PK/PD studies to support the early stage of drug candidate evaluation and assists our clients' decisions toward to advancing their portfolios.

​

The key study includes:

  1. Dosing Routes of administration

    • IV(Intravenous), PO (Per Oral), IP (Intraperitoneal), SC(Subcutaneously), ID(Intradermal), and IN(Intranasal)

  2. Dosing type

    • Acute dose, repeat dose and dose escalation

  3. Sample collection

    • Jugular vein cannulation, submandibular, tail vein, retro-orbital and cardiac

  4. Tissue distribution readout

    • Imaging (Bioluminescence/fluorescent/X-ray)

  5. Bioanalysis :

    • PK Solver

bottom of page